|Articles|June 1, 2004

Eyetech deal gives quick access to new research

New York-Eyetech Pharmaceuticals and Archemix Corp. will collaborate on the research and development of aptamers for use in the treatment of ophthalmic diseases.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME